PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
27470663-0	2016	Investigation into the interaction of losartan with human serum albumin and glycated human serum albumin by spectroscopic and molecular dynamics simulation techniques: A comparison study.	Losartan	38-46	albumin	Homo sapiens	58-71	
27470663-0	2016	Investigation into the interaction of losartan with human serum albumin and glycated human serum albumin by spectroscopic and molecular dynamics simulation techniques: A comparison study.	Losartan	38-46	albumin	Homo sapiens	91-104	
27470663-1	2016	The interaction between losartan and human serum albumin (HSA), as well as its glycated form (gHSA) was studied by multiple spectroscopic techniques and molecular dynamics simulation under physiological conditions.	Losartan	24-32	albumin	Homo sapiens	43-56	
12623509-11	2002	Serum albumin level increased significantly in the losartan group but was unchanged in the control group.	Losartan	51-59	albumin	Homo sapiens	6-13	
29258218-0	2017	In Vitro Investigation of the Interaction of Tolbutamide and Losartan with Human Serum Albumin in Hyperglycemia States.	Losartan	61-69	albumin	Homo sapiens	87-94	
34730021-0	2022	Candesartan, losartan and valsartan Zn(II) complexes interactions with bovine serum albumin.	Losartan	13-21	albumin	Homo sapiens	78-91	
34730021-2	2022	Methodology: The interaction of bovine serum albumin (BSA) with the metal complexes of antihypertensive drugs, Zn(II)/sartan complexes (candesartan, valsartan and losartan), was investigated using fluorescence quenching determinations at different temperatures.	Losartan	163-171	albumin	Homo sapiens	39-52	
35056715-0	2022	Changes in Glycated Human Serum Albumin Binding Affinity for Losartan in the Presence of Fatty Acids In Vitro Spectroscopic Analysis.	Losartan	61-69	albumin	Homo sapiens	26-39